« Previous
Next »
Fertility and Sterility
Volume 89, Issue 6
, Pages
1685-1693
, June 2008
Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization–intracytoplasmic sperm injection patients
To access this article, please choose from the options below
The research institutes of the participating centers were supported by Ferring BV, Hoofddorp, The Netherlands. P.G.A.H. has conducted clinical research sponsored by Abbott, Ferring, Organon, Schering, and Serono. F.J.B. has conducted clinical research sponsored by Wyeth, Ferring, Organon, and Serono.
PII: S0015-0282(07)01207-1
doi: 10.1016/j.fertnstert.2007.05.039
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 89, Issue 6
, Pages
1685-1693
, June 2008

